On February 11, we were honored to present at the Healthcare Conference Taipei 2026 hosted by J.P. Morgan and UC Berkeley at The Regent Taipei. Compared to our last presentation, we have achieved important milestones 🚀, expanded our clinical footprint, and made significant progress in strengthening our bioadhesive technology. 💪 Thanks to the UC Berkeley School of Public Health for the opportunity. And thank you to everyone we had the pleasure of meeting. 😊

💪 We're honored to share that MoleculeX has been ranked 13 Biotech Company in Taiwan on F6S this January 2026. Compared to last year, we've reached several important milestones. More hospitals in Taiwan have adopted our Oral Wound Dressing, and we received our second TFDA medical device license for our new product, MuCoat. Beyond this, multiple new products in our pipeline are actively under development, and we are preparing to bring them to market this year. Step by step, w